Breast cancer is heterogeneous, as indicated by the fact that tumours with identical morphologic and immunohistochemical characteristics have different clinical behaviour and treatment responses. This cleared the door for microarray-based global gene expression profiling (GEP) and new molecular subtyping techniques for breast cancer. Among all molecular subtypes, the triple...